Voices of Epilepsy interviewed epilepsy researchers this past spring to get their response to Phase II clinical trial results from an open-label study of cannabdiol in treatment resistant epilepsy. The data was presented at the 2015 American Academy of Neurology annual meeting.

May 1, 2015 CBD study shows promise, but more trials needed

May 14, 2015 Phase 3 trial to provide clearer picture of CBD’s side effects: researcher

For additional background, see the following press release from the American Academy of Neurology: Medical Marijuana Liquid Extract May Bring Hope for Children with Severe Epilepsy

In June, following a ruling from the Supreme Court that expanded the definition of medical marijuana beyond the dried form, Voices of Epilepsy interviewed parents who have children with refractory epilepsy.

June 18, 2015 Supreme Court’s medicinal marijuana ruling a relief for family of child with Dravet syndrome

June 25, 2015 CBD offers hope to people with seizure disorders, but more information, support, needed: Carol Clarke